AI Unveils Targets for Rare Sinonasal Cancer in Study
CAMBRIDGE, Mass. — Aug 4, 2026 — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company,…
Browsing Category